The potential of chitosam in ocular drug delivery

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 11, 2003, Pages 1451-1463

  Alonso, María José ^a   Sánchez, Alejandro ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHITOSAN; CYCLOSPORIN; DIAZEPAM; DRUG CARRIER; IDOXURIDINE; INDOMETACIN; LIPOSOME; MACROGOL; MICROSPHERE; N ACETYLGLUCOSAMINE; NANOPARTICLE; OFLOXACIN; OLIGOMER; POLYCAPROLACTONE; POLYLYSINE; TOBRAMYCIN; BIOMATERIAL; CHITIN; DRUG DERIVATIVE;

ADHESION; BIODEGRADATION; COATED PARTICLE; COLLOID; CONJUNCTIVA EPITHELIUM; CORNEA EPITHELIUM; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG MANUFACTURE; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENCY; DRUG RETENTION; DRUG TOLERANCE; DRUG TRANSPORT; EVIDENCE BASED MEDICINE; EYE; EYE DISEASE; GEL; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; WOUND HEALING; HISTOLOGY; HUMAN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; BIOCOMPATIBLE MATERIALS; CHITIN; CHITOSAN; CYCLOSPORINE; DRUG DELIVERY SYSTEMS; EYE; HUMANS;

EID: 0344876590     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357022476     Document Type: Review

References (76)

1. Aiba, S. I. (1993) Studies on chitosan: Relationship between N-acetyl group distribution pattern and chitinase digestibility of partially N-acetylated chitosans. Int. J. Biol. Macromol. 15: 241-245
2. Allan, C. R., Hadwiger, L. A. (1979) The fungicidal effect of chitosan on fungi of varying cell wall composition. Exp. Micol. 3: 285-287
3. Alonso, M. J. (1996) Nanoparticulate drug carrier technology. In: Cohen, S., Bernstein, H. (eds) Microparticulate Systems for the Delivery of Proteins and Vaccines. Marcel Dekker Inc., New York, pp 203-242
4. Artursson, P., Lindmark, T., Davis, S. S., Illum, L. (1994) Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11: 1358-1361
5. Aspden, T. J., Mason, J. D. T., Jones, N. S., Lowe, J., Skaugrud, O., Illum, L. (1997) Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J. Pharm. Sci. 86: 509-513
6. Balassa, L. L., Prudden, J. F. (1978) Application of chitin and chitosan in wound healing acceleration. Proceedings of the First International Conference on Chitin/Chitosan 295-305
7. Borchard, G., Lueben, H. L., De Boer, G. A., Coos Verhoef, J., Lehr, C. M., Junginger, H. E. (1996) The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption III: Effects of chitosan glutamate and carbomer on epithelial tight junctions in vitro. J. Control. Release 39: 131-138
8. Calvo, P., Thomas, C., Alonso, M. J., Vila Jato, J. L., Robinson, J. (1994) Study of the mechanisms of interaction of poly-E-caprolactone nanocapsules with the cornea by confocal laser scanning microscopy, Int. J. Pharm. 103: 283-291
9. Calvo, P., Alonso, M. J., Vila-Jato, J. L., Robionson, J. R. (1996) Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J. Pharm. Pharmacol. 48: 1147-1152
10. Calvo, P., Remuñan, C., Vila Jato, J. L., Alonso, M. J. (1997a) Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron emulsions. Colloid. Polym. Sci. 275: 46-53
11. Calvo, P., Vila-Jato, J. L., Alonso, M. J. (1997b) Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm. 153: 41-50
12. Calvo, P., Remuñán-López, C., Vila-Jato, J. L., Alonso, M. J. (1997c) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63: 125-132
13. Calvo, P., Remuñan-López, C., Vila-Jato, J. L., Alonso, M.J. (1997d) Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for protein and vaccines. Pharm. Res. 14: 1431-1436
14. Caramella, C. M., Rossi, S., Bonferoni, M. C. (1999) A rheological approach to explain the mucoadhesive behavior of polymer hydrogels. In: Mathioweitz, E. (ed.) Encyclopedia of Controlled Drug Delivery, Vol. 1. John Wiley & Sons Inc., New York, pp 25-65
15. De Campos, A., Sanchez, A., Alonso, M. J. (2001) Chitosan nanoparticles: A new vehicle for the improvement of the ocular retention of drugs. Application to cyclosporin A. Int. J. Pharm. 224: 159-168
16. De Campos, A., Diebold, Y., Carvalho, E. L. S., Sánchez, A., Alonso, M. J. (2002) De Campos A. (ed.) Evaluación biofarmacéutica de sistemas coloidales para el transporte de medicamentos por vía ocular. Doctoral Thesis, pp 48-76
17. De Campos, A. M., Sánchez, A., Gref, R., Calvo, P., Alonso, M. J. (2003) The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur. J. Pharm. Sci. 20: 73-81
18. Di Colo, G., Zambito, Y., Brugalassi, S., Serafinin, A., Saettone, M. F. (2002) Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts on poly(ethylene oxide). Int. J. Pharm. 248: 115-122
19. Dodane, V., Vilivalam, V. D. (1998) Pharmaceutical applications of chitosan. Pharma Sci. Technol. Today 1: 246-253
20. Dodane, V., Khan, M. A., Merwin, J. R. (1999) Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182: 21-32
21. Enriquez De Salamanca, A., Biebold, Y., Callejo, S., Jarrin, M., Vila, A., Alonso, M. J. (2002) 4th Int. Symposium on Ocular Pharmacology and Pharmaceutics. p. 38
22. Felt, O., Buri, P., Gurny, R. (1998) Chitosan: A unique polysaccharide for drug delivery, Drug Dev. Ind. Pharm. 24: 979-993
23. Felt, O., Furrer, P., Mayer, J. M., Plazonnet, B., Buri, P., Gurny, R. (1999a) Topical use of chitosan in ophthalmology: Tolerance assessment and evaluation of precorneal retention. Int. J. Pharm. 180: 185-193
24. Felt, O., Baeyens, V., Zignani, M., Buri, P., Gurny, R. (1999b) Mucosal drug delivery, ocular. In: Mathiowitz, E. (ed.) Encyclopedia of Controlled Drug Delivery, Vol. 1. John Wiley & Sons Inc., New York, pp 605-626
25. Felt, O., Carrel, A., Baehni, P., Buri, P., Gurny, R. (2000) Chitosan as tear substitute: A wetting agent endowed with antimicrobial efficacy. J. Ocular Pharmacol. 16: 261-270
26. Fernandez-Urrusuno, R., Calvo, P., Remuñan-López, C., Vila-Jato, J. L., Alonso, M. J. (1999) Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 16: 1576-1581
27. Fitzgerald, P., Handgraft, J., Wilson, C. G. (1987a) A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in rabbit. J. Pharm. Pharmacol. 39: 487-490
28. Fitzgerald, P., Handgraft, J., Kreuter, J., Wilson, C. G. (1987b) A scintigraphic evaluation of microparticulate ophthalmic delivery systems: Liposomes and nanoparticles. Int. J. Pharm. 40: 81-84
29. Genta, I., Conti, B., Perugini, P., Pavaneto, F., Spadaro, A., Puglisi, G. (1997) Bioadhesive microspheres for ophthalmic administration of acyclovir. J. Pharm. Pharmacol. 49: 737-742
30. Greaves, J. L., Olejnik, O., Wilson, C. G. (1992) Polymers and the precorneal tear film. STP Pharma Sci. 2: 13-33
31. Greaves, J. L., Wilson, C. G. (1993) Treatment of diseases of the eye with mucoadhesive delivery systems. Adv. Drug Del. Rev. 11: 349-383
32. Greiner, J. V., Weidman, T. A., Korb, D. R., Allansmith, M. R. (1985) Histochemical analysis of secretory vesicles in nongoblet conjunctival epithelial cells. Acta Ophthalmol. (Copenh.) 63: 89-92
33. Hassan, E. E., Gallo, J. M. (1990) A simple rheological method for the in vivo assessment of mucin-polymer bioadhesive bond strength. Pharm. Res. 7: 491-495
34. Henriksen, I., Green, K. L., Smart, J. D., Smistad, G., Karlsen, J. (1996) Bioadhesion of hydrated chitosans: An in vitro and in vivo study. Int. J. Pharm. 145: 231-240
35. Hirano, S., Seino, H., Akiyama, Y., Nonaka, I. (1989a) Biocompatibility of chitosan by oral and intravenous administration. Polym. Eng. Sci. 59: 897-901
36. Hirano, S., Tsuchida, H., Nagao, N. (1989b) N-acetylation in chitosan and the rate of its enzymic hydrolysis. Biomaterials 10: 574-576
37. Hirano, S., Seino, H., Akiyama, I., Nonaka, I. (1990) Chitosan: A biocompatible material for oral and intravenous administration. In: Gebelein, C. G., Dunn, R. L. (eds) Progress in Biomedical Polymers. Plenum Press, New York, pp 283-289
38. Illum, L. (1998) Chitosan and its use as a pharmaceutical excipient Pharm. Res. 15: 1326-1331
39. Janes, K. A., Alonso, M. J. (2003) Depolymerized chitosan nanoparticles for protein delivery: Preparation and characterization. J. Appl. Polym. Sci. 88: 2769-2776
40. Janes, K. A., Calvo, P., Alonso, M. J. (2001) Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 47: 83-97
41. Kas, H. S. (1997) Chitosan: Properties, preparation and application to microparticulate systems. J. Microencapsul. 14: 659-711
42. Kaur, I. P., Smitha, R. (2002) Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 28: 353-369
43. Knapczyk, J., Krówczynski, L., Krzck, J., Brzeski, M., Nirnberg, E., Schenk, D., Struszcyk, H. (1989) Requirements of chitosan for pharmaceutical and biomedical applications. In: Skak-Braek, G., Anthonsen, T., Sandford, P. (eds) Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications. Elsevier, London, pp 657-663
44. Koch, M. A., Dodane, V., Khan, M. A., Merwin, J. R. (1998) Chitosan induced effects on epithelial morphology as seen by confocal scanning microscopy. Scanning 20: 262-263
45. Lang, J. C. (1995) Ocular drug delivery conventional ocular formulations. Adv. Drug Deliv. Rev. 16: 3943
46. Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., Leverge, R. (1998) Ophthalmic drug delivery systems - Recent advances. Prog. Retin. Eye Res. 17: 33-58
47. Lehr, C. M., Bowstra, J. A., Schacht, E. H., Junginger, H. E. (1992) In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78: 43-48
48. Losa, C., Marchal-Heussler, L., Orallo, F., Vila-Jato, J. L., Alonso, M. J. (1993) Design of new formulations for topical ocular administration: Polymeric nanocapsules containing metipranolol. Pharm. Res. 10: 80-87
49. Malette, W. G., Quigly, H. J., Geines, R. D. (1983) Chitosan: A new hemostatic. Ann. Thorac. Surg. 36: 1-3
50. Markey, M. L., Bowman, L. M., Bergamini, M. V. W. (1989) Contact lenses made of chitosan. In: Skjak-Braek, G., Antonsen, P., Sanford, P. (eds) Chitin and Chitosan: Sources, Chemistry and Biochemistry, Physical Properties and Applications. Elsevier Applied Science, London, pp 713-717
51. Maurice, D. M. (1993) Prolonged-action drops. Int. Ophthalmol. Clin. 33: 81-91
52. Moore, J. C., Tiffany, J. M. (1981) Human ocular mucus. Chemical studies. Exp. Eye Res. 33: 203-212
53. Mucha, M. (1997) Rheological characteristics of semi-dilute chitosan solutions. Macromol. Chem. Phys. 198: 471-484
54. Muzzarelli, R. A. A. (1983) Chitin and its derivatives, new trends of applied research, Carbohydrate Polymers 3: 53-75
55. Muzzarelli, R. A. A. (1993) Biochemical significance of exogenous chitins and chitosans in animals and patients, Carbohydrate Polym. 20: 7-16
56. Muzzarelli, R. A. A. (1997) Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell. Mol. Life Sci. 53: 131-140
57. Nordveit, R. J., Varum, K. M., Smidsrod, O. (1994) Degradation of fully water-soluble, partially N-acetylated chitosans with lysozyme. Carbohydrate Polym. 24: 253-260
58. Pangburn, S. H., Trescony, P. V., Heller, J. (1982) Lysozyme degradation of partially deacetylated chitin, its films and hydrogels. Biomaterials 3: 105-108
59. Paul, W., Sharma, C. (2000) Chitosan, a drug carrier for the 21st century. STP Pharma Sci. 10: 5-22
60. Remuñan-Lopez, C., Bodmeier, R. (1996) Mechanical and water vapor transmission properties of polysaccharide films. Drug Dev. Ind. Pharm. 22: 1201-1209
61. Richardson, S. C. W., Kolbe, H. V. J., Duncan, R. (1999) Potential of low molecular weight chitosan as a DNA delivery system: Biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178: 231-243
62. Rohen, J. W., Lütjen-Drecoll, E. (1992) Functional morphology of the conjunctiva. The Dry Eye: A Comprehensive Guide. In: Lemp, M. A., Marquard, R. (eds) pp 35-63
63. Romanelli, L., Valcri, P., Mortone, L. A., Pimpenella, G., Graziani, G., Tita, B. (1994) Ocular absorption and distribution of bendazac after topical administration to rabbits with different vehicles. Life Sci.54: 877-885
64. Sall, K. N., Kreter, J. K., Keates, R. H. (1987) The effect of chitosan on corneal wound healing. Ann. Ophthalmol. 19: 31-33
65. Sashiwa, H., Saimoto, H., Shigemasa, Y., Ogawa, R., Tokura, S. (1990) Lysozyme susceptibility of partially deacetylated chitin. Int. J. Biol. Macromol. 12: 295-296
66. Schipper, N. G. M., Vårum, K. M., Artursson P. (1996) Chitosan as absorption enhancers for poorly absorbable drugs 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelia (Caco-29 cells). Pharm. Res. 13: 1686-1692
67. Schipper, N. G. M., Olsson, S., Hoostraate, A. J., De Boer, A. G., Vå, K. M., Artursson, P. (1997) Chitosan as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm. Res. 14: 923-929
68. Singla, A. K., Chawla, M. (2001) Chitosan: Some pharmaceutical and biological aspects - An update. J. Pharm. Pharmacol. 53: 1047-1067
69. Sintzel, M. B., Bernatchez, S. E., Tabatabay, C., Gurny, R. (1996) Biomaterials in ophthalmic drug delivery. Eur. J. Pharm. Biopharm. 42: 358-374
70. Smolin, G., Okumoto, M., Feiler, S., Condon, D. (1981) Idoxuridine-liposome therapy for herpes simplex keratitis. Am. J. Ophthalmol. 91: 220-225
71. Vila, A., Sánchez, A., Tobío, M., Calvo P., Alonso, M. J. (2002) Design of biodegradable particles for protein delivery. J. Control. Release 78: 15-24
72. Wang, W., Xu, D. (1994) Viscosity and flow properties of concentrated solutions of chitosan with different degrees of acetylation. Int. J. Biol. Macromol. 16: 149-152
73. Wood, R. W., Lee, V. H. K., Kreuter, J., Robinson, J. R. (1985) Ocular disposition of poly-hexyl-2-cyano(3-14C)acrylate nanoparticles in the albino rabbit. Int. J. Pharm. 23: 175-183
74. Zimmer, A., Kreuter, J. (1995) Microspheres and nano-particles used in ocular drug delivery. Adv. Drug Del. Rev. 16: 61-73
75. Zimmer, A., Kreuter, J., Robinson, J. K. (1991) Studies on the transport pathway of PBCA nanoparticles in ocular tissues. J. Microencapsulation 8: 497-504
76. Zimmer, A. K., Chetoni, P., Saettone, M. F., Zerbe, H., Kreuter, J. (1995) Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers. J. Control. Release 33: 31-46